Septofort

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Septofort

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate
Form Medicated Lozenge
Pharmacological class Antiseptic and Disinfectant (Antimicrobial Agent)
Common use Local disinfection of the oral cavity and throat
Origin Synthetic (Biguanide compound)

What is Septofort and What Type of Medicine is It?

Septofort is a non-prescription medicine formulated as a medicated lozenge, intended exclusively for local treatment within the oral cavity and throat. The preparation is scientifically classified as an Antiseptic and Disinfectant, placing it within the biguanide class of antimicrobial agents.

This classification underscores its primary role: to provide concentrated germicidal action directly at the site of administration, which is the oral (buccal/pharyngeal) route. Septofort is distinguished by its medicated lozenge form, which, unlike liquid formulations, is designed for sustained release and prolonged contact with the target mucosa.


Active Ingredient and Composition

The therapeutic efficacy of Septofort is centered on its core component, Chlorhexidine Gluconate, which is a synthetic single-ingredient product derived from a biguanide structure. Chlorhexidine is widely used as a topical antiseptic for skin and mucous membranes.

Chlorhexidine Gluconate is a powerful cationic compound recognized for its broad-spectrum antimicrobial activity. The final preparation is notably formulated to be sugar-free, utilizing solid pharmaceutical excipients, such as Sorbitol, a key differentiating feature that makes the lozenges an appropriate option for specific patient groups such as diabetics.


General Purpose and Antiseptic Action

The general purpose of Septofort is to serve as an effective topical disinfectant, working to reduce the microbial load found in the throat and oral cavity. For example, it is typically used in situations where a simple disinfectant action is required to address microbial colonization in the pharyngeal area.

The Chlorhexidine Gluconate molecule achieves this through a high-affinity cationic binding to cell walls of microorganisms, a process that disrupts the cell membrane and leads to cellular leakage and elimination. This provides a robust and long-lasting antibacterial effect that is confined to the treated area, supporting the relief of local discomfort associated with the presence of pathogens.

What side effects are possible with Septofort?

Possible Side Effects and Safety Information

Septofort (Chlorhexidine Gluconate) safety information is structured around expected local effects in the mouth and the rare potential for systemic allergic reactions, as documented by regulatory agencies.


Frequency-Classified Adverse Reactions

Adverse reactions are classified based on reported frequency in official product labeling:

Classification Common Reactions Rare/Very Rare Reactions
Immune / Systemic N/A Severe Hypersensitivity Reactions, including Anaphylaxis
Gastrointestinal / Local Taste disturbance (dysgeusia), oral/dental staining, and local mucosal irritation Swelling of the parotid glands

These local effects are classified under Gastrointestinal Disorders in regulatory system-organ-classifications, reflecting the product's direct contact with the oral mucosa. The potential for taste alteration and staining is noted in product information as being more noticeable with prolonged or continuous use.


Safety Constraints and Special Populations

Official labeling defines specific safety limitations. The product is contraindicated for use in individuals with a known history of hypersensitivity to chlorhexidine or any of its excipients. Additionally, the medicine is for local oral use only and must not be swallowed.

Regulatory documents also address specific groups:

  • Pediatric Use: Safety and effectiveness have not been established in children under the age of 18.
  • Pregnancy and Lactation: Use during pregnancy is advised only if clearly needed. It is unknown if the active ingredient is excreted in human milk, advising caution during nursing.

The overall regulatory profile highlights that while common effects are localized and expected, the risk of a severe anaphylactic reaction, though rare, remains a documented serious adverse reaction.

Overdose and Emergency Response

Septofort Overdose and When to Seek Help

The information regarding overdose is derived from official regulatory documentation and addresses two primary scenarios: over-ingestion and severe systemic reactions.


Documented Overdose Manifestations

Over-ingestion of the lozenges (swallowing a large quantity) may lead to gastric distress and other gastrointestinal signs. Officially documented clinical manifestations of high-level exposure include nausea, vomiting, abdominal pain, and diarrhea. In severe, rare cases, systemic effects such as profound hypotension (low blood pressure) or coma have been associated with massive ingestion.

Immediate Actions and Severe Outcomes

Septofort carries a regulatory warning regarding the potential for a rare, serious allergic reaction known as anaphylaxis, which is defined as a life-threatening condition. Symptoms indicative of such a severe reaction include difficulty breathing (wheezing), swelling of the face or throat, and rapidly progressing hives or rash.

When Urgent Medical Help is Required

  • Seek immediate medical attention if any symptoms of a serious allergic reaction are observed.
  • Contact emergency services (Call 911 or local equivalent) or a Poison Control Center right away in cases of suspected serious overdose or severe adverse reactions.

Management for over-ingestion is symptomatic and supportive. No specific antidote is officially documented. Hospital monitoring, including an ECG and close observation of vital signs, may be required for complex cases. Regulatory guidance specifically notes the risk of accidental ingestion in a small child.

Therapeutic Uses of Septofort

What Septofort Treats: Main Uses and Benefits

Septofort is relevant across therapeutic domains where short-term symptomatic assistance is appropriate for the mouth and throat. This active ingredient is generally applied to help with symptoms related to mouth infections, mouth ulcers, gum disease, and sore throats.

This medication is commonly used to help with symptoms of acute throat soreness and pharyngeal irritation, as well as mild gum inflammation (gingivitis), and localized discomfort from common oral lesions. It is applied in clinical settings that involve acute or disruptive symptom patterns, such as during episodes of sudden discomfort or periods of heightened distress.

The lozenge provides support that may assist with maintaining functional stability when symptoms interfere with routine activities, and supports patients during episodes of heightened discomfort. The preparation is applied in scenarios where additional management of discomfort is required.


Quick Fact: Relief for Acute Discomfort
Primary Focus: Symptomatic relief for soreness and inflammation.
Relevant Conditions: Pharyngitis, Gingivitis, Mouth Ulcers.
Patient Benefit: Contributes to improved comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Septofort? (Official Eligibility Profile)

The regulatory profile for Septofort (Chlorhexidine Gluconate lozenges) defines eligibility primarily based on age and known sensitivities, strictly outlining who is permitted, restricted, or prohibited from using the medicine according to official documentation.


Official Eligibility Statements

Classification Population Group Condition/Restriction
Absolute Contraindication Individuals with known hypersensitivity Must not be used if allergic to chlorhexidine gluconate or any excipient.
Not Recommended Children under 12 years of age Safety and efficacy are not established below this minimum age threshold.
Conditional Use Pregnant or Nursing Mothers Use during pregnancy is permitted only if clearly needed; caution is advised when breastfeeding.
Permitted Use Diabetics The lozenge formulation is sugar-free, allowing use in the diabetic population.

Eligibility Context

Adults and adolescents aged 12 years or over are generally permitted to use the medicine. Regulatory advisories also note that caution is advised for older adults due to the potential for decreased organ function (e.g., hepatic or renal function).

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Septofort, which contains the antiseptic Chlorhexidine Gluconate, is defined by its localized action and minimal absorption into the bloodstream. Regulatory documents confirm that systemic pharmacokinetic interactions are considered negligible, meaning the medicine does not typically alter the body's processing of other medications through metabolic pathways like CYP enzymes or drug transporters. Consequently, the official labeling for this oral route of administration does not list any systemic drug-drug combinations as formally contraindicated.

The most relevant and documented interaction is a local chemical incompatibility with anionic compounds and anionic surfactants. These substances, which are commonly found in oral hygiene products, including most toothpastes, can chemically inactivate Chlorhexidine Gluconate at the site of administration, resulting in a reduction of the lozenge’s local antiseptic effectiveness.

This incompatibility imposes a mandatory timing rule documented in the prescribing information: to avoid reduced efficacy, the administration of the lozenge must be separated from the use of toothpaste. No specific population-dependent interaction considerations, such as heightened risks in hepatic or renal impairment, are noted in the regulatory documents, reflecting the drug’s limited systemic profile.

Mechanism of Action

Mechanism of Action: Chlorhexidine Gluconate

Septofort (Chlorhexidine Gluconate) operates via a direct, localized physical mechanism targeting the structural integrity of microorganisms on the oral and pharyngeal mucosa. The primary action is a potent electrostatic interaction where the cationic drug molecule rapidly binds to the negatively charged microbial cell walls and outer membranes.

This binding immediately destabilizes the microbial cell membrane, causing an increase in permeability and subsequent leakage of low-molecular-weight cytoplasmic contents. At effective local concentrations, the molecule penetrates the cell interior, initiating irreversible coagulation of essential intracellular macromolecules, including proteins and nucleic acids. This cascade results in a non-specific bactericidal and fungicidal action, leading to the elimination of pathogens in the local environment.

Furthermore, the mechanism is characterized by high substantivity; the molecule's strong positive charge enables prolonged binding to the mucosal tissues. This mucosal retention creates a local reservoir, ensuring the active substance remains concentrated at the site of application over an extended period. The mechanism is entirely localized and does not involve the modulation of human physiological pathways, such as CNS receptors or inflammatory mediator systems.

Dosage and Administration Information

How to Use Septofort: Official Administration Instructions

Septofort (Chlorhexidine Digluconate 2 mg Lozenge) is a medicine intended for local application, meaning its use is restricted to the oromucosal route—the mouth and throat. Correct administration is vital to ensure the active ingredient is released slowly and contacts the mucosal surfaces as required.

Standard Dosage and Frequency

Administration for adults and adolescents follows a strict schedule that defines both the single dose and the maximum daily allowance.

Population Single Dose Frequency Minimum Interval
Adults and Adolescents One tablet (2 mg) Three times daily (3x/day) 2 hours between doses

Administration Method and Timing

The lozenge must be administered according to specific procedural steps to facilitate its local effect.

  • Method: The tablet must be allowed to dissolve slowly in the mouth (sucked); it should not be chewed or swallowed whole.
  • Timing: Administration must occur after meals.
  • Composition Note: The lozenge formulation is sugar-free, utilizing Sorbitol as a pharmaceutical excipient.

Use in Children

Dosing is adjusted for younger patients, and the medicine is subject to an age restriction:

  • Children 5–12 years: The dose is 1/2 to one tablet, taken twice daily.
  • Children Under 5 Years: The product is not recommended for use in this age group.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Septofort

The research available for the active ingredient in Septofort, Chlorhexidine Gluconate, contributes to the broader evidence landscape describing how it has been observed in clinical settings. This overview describes the types of studies that have been conducted, the areas of health they focused on, and where evidence remains limited or still emerging.


Evidence for Acute Sore Throat and Oral Plaque

The evidence for this active ingredient was observed in studies focusing on acute symptoms and local antiseptic control. Research has explored the use of Chlorhexidine in short-term Randomized Controlled Trials (RCTs) related to throat discomfort. These studies primarily monitored outcomes related to physical discomfort, such as sore throat pain intensity.

Separately, the evidence base for reducing plaque accumulation and mild gingival inflammation is generally characterized as High level, primarily drawing from Systematic Reviews and Comprehensive Meta-analyses which monitored changes in the Plaque Index and Gingival Index.


Form-Specific Limitations and Research Gaps

Research highlights that many findings regarding throat symptoms involved lozenges containing Chlorhexidine in fixed combinations with other compounds, which means the single-ingredient profile is not yet clear. Furthermore, the majority of the high-level evidence for plaque and gingivitis is derived from the mouthwash form, not the lozenge dosage form itself.

Long-term effects are not fully established, as most clinical research was observed in trials assessing short-term symptom patterns over days or weeks. Additionally, data for certain groups remain insufficient, including evidence for older adults, pregnant patients, or those with multiple underlying health conditions (comorbidities). The clinical research on Chlorhexidine lozenges for more severe or chronic oral conditions is limited.

Frequently Asked Questions (FAQ)

Common questions about Septofort (FAQ)


Q: Can Septofort be used by children?

Official documentation for Septofort presents differing age cut-offs depending on the source. Some official instructions provide specific dosing information for children between 5 and 12 years of age, while other regulatory summaries state that safety and effectiveness have not been established in children under 18 years.

Patients are encouraged to review the specific prescribing information or consult a healthcare professional regarding use for specific age groups.


Q: Is Septofort considered appropriate for older adults (seniors)?

Studies often have limited data on subjects aged 65 and over, making it difficult to determine if this group responds differently to treatment. Official advisories commonly suggest that caution is advised for older adults due to the general potential for decreased organ function, which is a common factor to consider in older adults.


Q: Is it necessary to finish the entire course of Septofort even if I feel better?

While general guidance for short-term oral treatments often recommends completing a course, some instructions advise contacting a doctor if symptoms do not improve or get worse after three to four days.

Regarding the total duration of use for Septofort, it is important to confirm this with a healthcare professional.


Q: Does alcohol interact with Septofort?

Regulatory warnings primarily focus on local chemical incompatibility with anionic agents, such as those found in toothpaste, since Septofort is poorly absorbed into the bloodstream. There is no known systemic interaction with alcohol. However, official guidance advises that patients discuss alcohol use with a healthcare professional.


Q: Are there any specific food or drinks that should be avoided with Septofort?

The official administration instructions state that use of the lozenge must occur after meals. Some external information notes that separating the consumption of beverages like coffee or tea by at least an hour from use may help reduce the potential for staining.


Q: What types of prescription medicines are officially mentioned as interacting with Septofort?

Due to its localized action, official documents for the lozenge form state that systemic pharmacokinetic interactions are negligible, meaning the body's processing of other medicines is not typically affected. Consequently, no systemic drug-drug combinations are formally contraindicated in the official prescribing information for Septofort. The only key interaction mentioned is a local incompatibility with anionic compounds.


Q: What is the maximum allowed period of time Septofort can be used continuously?

Official guidelines recommend using the lozenges only for a short period of time. The total duration of use is generally restricted because the risk of common local effects, such as oral/dental staining, becomes more noticeable with prolonged or continuous use. It is recommended to consult a healthcare professional for use extending beyond a few days.


Q: How does the action of Septofort differ from a typical pain reliever?

Septofort is classified as an Antiseptic and Disinfectant, meaning its primary action is a localized physical mechanism that disrupts the cell walls of microorganisms in the mouth and throat. This differs from typical pain relievers, which typically act by modulating the body’s own physiological pathways, such as inflammatory mediator systems or CNS receptors, to reduce pain.


Q: Is Septofort generally taken for a short period or a longer time?

The medicine is intended for local application in the mouth and throat and is generally indicated for short-term use only. Official guidance advises seeking professional help if symptoms do not improve or worsen after three to four days, reinforcing the short duration of intended use.


Q: Is it common to feel tired after taking Septofort?

Official adverse reaction listings, which classify side effects based on how often they are reported in studies, do not include fatigue, tiredness, or somnolence among the known side effects for the lozenge form.


Q: Can Septofort affect how I taste food or drinks?

Yes, taste disturbance (also known as dysgeusia) is listed as a common side effect in the official product information. This taste alteration is generally temporary and may persist for a short duration after the lozenge is used.


Q: Is there a known link between Septofort and changes in sleep?

Official adverse reaction listings, based on regulatory review of clinical data, do not include any mention of changes in sleep or insomnia for the lozenge formulation.


Q: Can taking Septofort make me feel dizzy?

Official adverse reaction listings for the lozenge form do not include dizziness or vertigo among the common or known side effects.


Q: What is the official information regarding Septofort and driving or operating machinery?

Official documents, such as the Summary of Product Characteristics (SmPC), state that the use of chlorhexidine lozenges has no or negligible influence on the ability to drive and use machines. This is consistent with its localized action and minimal absorption into the bloodstream.


Q: What happens if a person misses a planned use of Septofort?

Official patient instructions advise that if a dose is forgotten, it is typically taken as soon as it is remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be continued without taking a double dose.


Q: Is it safe to take multivitamins while using Septofort?

The interaction profile is defined by the medicine's localized action and negligible systemic absorption. Therefore, there is no known systemic interaction between this local antiseptic and the compounds in standard multivitamins. Patients are generally advised to inform their healthcare professional about all supplements being used.


Q: Is there a risk of interaction between Septofort and herbal supplements?

Official labeling typically does not list specific interactions with herbal supplements due to the drug's localized action and very low absorption into the body. While systemic interactions are unlikely, official patient guidance recommends informing a healthcare professional about all supplements, including herbal products, that are currently being used.


Q: Is Septofort available without a prescription in some countries?

The active ingredient, Chlorhexidine, is available in some formulations as an Over-The-Counter (OTC) or non-prescription medicine in various regions globally. However, regulations differ by country; in some places, certain concentrations or forms may still require a prescription.


Q: Can Septofort be crushed or split?

The lozenge is specifically designed for a sustained, local effect; therefore, administration instructions specify that it must be allowed to dissolve slowly in the mouth. It is explicitly stated that the lozenge should not be chewed or swallowed whole.


Q: What are the signs of an allergic reaction to Septofort?

Signs of a rare but serious allergic reaction (hypersensitivity) may include severe symptoms such as wheezing or difficulty breathing, swelling of the face, hives, severe rash, or shock. The product is formally contraindicated and must not be used by individuals with a known hypersensitivity to the active substance or any of its ingredients.


Q: Can Septofort be taken on an empty stomach?

Official administration instructions state that use of the lozenge is planned to occur after meals.


Q: Does Septofort cause dry mouth?

Official adverse reaction listings for the lozenge form may not always list dry mouth, but external patient information for various chlorhexidine oral products does note dry mouth as a possible side effect, often categorized as less common.


Q: Can Septofort affect blood pressure readings?

The active ingredient is very poorly absorbed from the oral route and no detectable blood levels have been found following oral use. Due to its entirely localized action, systemic effects on the body, such as changes in blood pressure, are highly unlikely.


Q: Is Septofort known to cause temporary changes in vision?

Official adverse reaction listings do not include any mention of temporary changes in vision for the lozenge formulation.


Q: Is Septofort considered a first-line treatment?

Official research evidence notes that for its stated uses, the active ingredient is generally regarded as an adjunctive treatment, meaning it is used in addition to or secondary to other primary treatments or measures.


Q: Can using Septofort cause headaches?

Official adverse reaction listings, based on regulatory data review, do not include headaches among the common or known side effects for the lozenge form.

How should Septofort be stored and disposed of?

How to Store and Dispose of Septofort

Septofort lozenges must be stored according to specific regulatory requirements to maintain product stability and ensure safety.

Storage Conditions

Detail Requirement
Temperature Store at room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep from freezing and excessive heat (above 40 C). Protect from direct light and moisture in a dry place.
Packaging Store in a closed container or the original packaging.
Child Safety Must be kept out of the reach of children.

Disposal Instructions

Expired or unused Septofort must not be discarded with household trash or allowed to enter the sewage system, as the active substance may be environmentally harmful. Disposal should follow local, national, and international regulations, and patients should consult a healthcare professional or pharmacist for specific instructions on discarding the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Septofort found in:

A-Z Index: